Qihong Zhao
Anhui Medical University(CN)Peter MacCallum Cancer Centre(AU)
Publications by Year
Research Areas
Chemokine receptors and signaling, Cytokine Signaling Pathways and Interactions, Psoriasis: Treatment and Pathogenesis, Immune Cell Function and Interaction, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43(2016)467 cited
- → Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors(2021)122 cited
- → Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases(2010)113 cited
- → CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma(2022)60 cited
- → Microbiota Metabolite Short-Chain Fatty Acids Facilitate Mucosal Adjuvant Activity of Cholera Toxin through GPR43(2019)59 cited
- → Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis(2022)54 cited
- → Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist(2020)42 cited
- → BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate(2021)39 cited
- → RORγt Represses IL-10 Production in Th17 Cells To Maintain Their Pathogenicity in Inducing Intestinal Inflammation(2018)38 cited
- → Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt—Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy(2019)37 cited